Results for tag: "N6 Cyclopentyladenosine"

N6 Cyclopentyladenosine (N6-CPT) is a drug used in the treatment of cardiovascular diseases. It is a selective agonist of the A2A adenosine receptor, which is involved in the regulation of blood pressure and heart rate. N6-CPT has been shown to reduce the risk of stroke and heart attack in patients with coronary artery disease. It has also been used to treat hypertension, angina, and congestive heart failure. N6-CPT is available in both oral and intravenous formulations. It is typically administered as a single daily dose, although some patients may require multiple doses. The drug is generally well tolerated, with few side effects reported. The N6-CPT market is a growing one, with many companies developing and marketing the drug. Some of these companies include AstraZeneca, Merck, Pfizer, and Novartis. Show Less Read more